Analyses of data from three studies provide insight into the use of Enbrel (etanercept) in the treatment of three conditions for which Enbrel is indicated: moderate-to-severe rheumatoid arthritis (RA), psoriatic arthritis (PsA) and ankylosing spondylitis (AS). These analyses, presented during the European League Against Rheumatism (EULAR) Annual Meeting in Copenhagen, add to the body of evidence ...
Discuss   Tell a friend   Bury

Comments Who Voted Related Links